# A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers

> **NCT00991705** · PHASE1 · COMPLETED · sponsor: **Boryung Pharmaceutical Co., Ltd** · enrollment: 28 (actual)

## Conditions studied

- Essential Hypertension

## Interventions

- **DRUG:** Atorvastatin
- **DRUG:** Fimasartan

## Key facts

- **NCT ID:** NCT00991705
- **Lead sponsor:** Boryung Pharmaceutical Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-07
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2009-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00991705

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00991705, "A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00991705. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*